Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b379f20a4a03565e28f3ae682690452c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5079 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2014-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6118d3fac25a2ec81fa59c2665a9d2a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394a85feea54980bdf567b7dede3170f |
publicationDate |
2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3047279-A1 |
titleOfInvention |
Method of screening for compounds useful in the treatment of alzheimer disease |
abstract |
The present invention relates to a method of screening for compounds useful in the treatment of Alzheimer disease using a signature based on mitochondrial behaviour variables. The invention also relates to a method for diagnosing Alzheimer disease and a method for monitoring the response of a subject affected with Alzheimer disease to therapy. |
priorityDate |
2013-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |